Drug Type CRISPR/Cas |
Synonyms- |
Target |
Mechanism LMNA modulators(lamin A/C modulators) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |